| Next 10 |
Ad
BIOYF News and Press Biosyent Inc
home / stock / bioyf / bioyf news
News | Biosyent Inc (OTCMKTS:BIOYF)
-
2025-03-14 16:58:02 ET BioSyent Inc. (BIOYF) Q4 2024 Results Conference Call March 13, 2025 05:30 PM ET Company Participants Rene Goehrum - President and CEO Presentation Rene Goehrum Welcome to the BioSyent Inc. Q4 and Fiscal Year 2024 results presen...
-
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key highlights include: Return on Equity for FY 2024 was 21% as com...
-
MISSISSAUGA, Ontario, March 06, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2024 on Thursday, March 13, 2025 after market hours. A pres...
-
2025-01-31 08:35:51 ET More on BioSyent BioSyent Inc. (BIOYF) Q3 2024 Earnings Call Transcript BioSyent announces renewal of normal course issuer bid BioSyent reports GAAP EPS of C$0.20, revenue of C$9.56M Historical earnings data for BioSyent&n...
-
MISSISSAUGA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on March 14, 2...
-
2024-11-20 09:57:52 ET More on BioSyent Historical earnings data for BioSyent Dividend scorecard for BioSyent Financial information for BioSyent Read the full article on Seeking Alpha For further details see: BioSyent reports GAAP EPS of C$0.20, r...
-
MISSISSAUGA, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2024. Key highlights include: Return on Average Equity for TTM September...
-
MISSISSAUGA, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on December 1...
-
MISSISSAUGA, Ontario, Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2024 on Wednesday, November 20, 2024 before market opening. A pr...
-
MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc., has entered into an agreement to acquire certain assets enabling it to sup...
Stock Information
Get BIOYF Alerts
News, Short Squeeze, Breakout and More Instantly...
Biosyent Inc Company Name:
BIOYF Stock Symbol:
OTCMKTS Market:
-0.9% G/L:
$7.748 Last:
400 Volume:
$7.89 Open:
$7.748 Close:
Biosyent Inc Website:
Ad
-
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key highlights include: Return on Equity for FY 2024 was 21% as com...
-
MISSISSAUGA, Ontario, March 06, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2024 on Thursday, March 13, 2025 after market hours. A pres...
-
MISSISSAUGA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on March 14, 2...